 Paul Buehler
Concepts (484)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemoglobins | 66 | 2026 | 365 | 10.670 |
Why?
| | Anemia, Sickle Cell | 20 | 2026 | 288 | 4.460 |
Why?
| | Haptoglobins | 25 | 2026 | 63 | 4.350 |
Why?
| | Hemopexin | 12 | 2025 | 34 | 3.590 |
Why?
| | Erythrocytes | 27 | 2026 | 708 | 3.270 |
Why?
| | Oxygen | 28 | 2026 | 998 | 3.210 |
Why?
| | Hemolysis | 22 | 2026 | 213 | 2.780 |
Why?
| | Blood Substitutes | 15 | 2024 | 28 | 2.670 |
Why?
| | Erythrocyte Transfusion | 9 | 2024 | 211 | 2.050 |
Why?
| | Thrombin | 7 | 2023 | 169 | 1.850 |
Why?
| | Extracellular Vesicles | 3 | 2023 | 163 | 1.840 |
Why?
| | Heme | 15 | 2025 | 84 | 1.800 |
Why?
| | Guinea Pigs | 23 | 2024 | 162 | 1.720 |
Why?
| | Cation Transport Proteins | 4 | 2026 | 116 | 1.630 |
Why?
| | Iron | 18 | 2025 | 346 | 1.570 |
Why?
| | Fibrinolysin | 4 | 2022 | 21 | 1.460 |
Why?
| | Transferrin | 5 | 2025 | 50 | 1.370 |
Why?
| | Homeostasis | 3 | 2020 | 641 | 1.370 |
Why?
| | Kidney | 13 | 2020 | 1507 | 1.310 |
Why?
| | Oxidation-Reduction | 26 | 2020 | 1092 | 1.220 |
Why?
| | Complement C1 Inhibitor Protein | 4 | 2023 | 11 | 1.140 |
Why?
| | Animals | 84 | 2026 | 38080 | 1.140 |
Why?
| | Blood Preservation | 10 | 2023 | 310 | 1.040 |
Why?
| | Blood Transfusion | 6 | 2021 | 401 | 1.000 |
Why?
| | Hypertension, Pulmonary | 7 | 2026 | 1972 | 0.950 |
Why?
| | Oxyhemoglobins | 5 | 2021 | 24 | 0.950 |
Why?
| | Diagnostic Equipment | 1 | 2025 | 5 | 0.930 |
Why?
| | Thrombosis | 4 | 2022 | 401 | 0.920 |
Why?
| | Oximetry | 3 | 2021 | 130 | 0.860 |
Why?
| | Hydrogen Peroxide | 12 | 2021 | 339 | 0.840 |
Why?
| | Hypoxia | 7 | 2026 | 1191 | 0.830 |
Why?
| | Electron Spin Resonance Spectroscopy | 7 | 2025 | 98 | 0.810 |
Why?
| | Thrombomodulin | 3 | 2022 | 14 | 0.810 |
Why?
| | Thrombotic Microangiopathies | 2 | 2020 | 20 | 0.780 |
Why?
| | Apoproteins | 3 | 2020 | 15 | 0.770 |
Why?
| | Hypercholesterolemia | 1 | 2023 | 102 | 0.750 |
Why?
| | Oxidative Stress | 16 | 2025 | 1376 | 0.720 |
Why?
| | Drug Design | 3 | 2021 | 173 | 0.700 |
Why?
| | Ascorbic Acid | 6 | 2019 | 180 | 0.700 |
Why?
| | Shock, Hemorrhagic | 1 | 2023 | 201 | 0.670 |
Why?
| | Nitric Oxide | 11 | 2021 | 899 | 0.670 |
Why?
| | Antibodies, Bispecific | 1 | 2021 | 62 | 0.660 |
Why?
| | Purpura, Thrombotic Thrombocytopenic | 1 | 2020 | 15 | 0.660 |
Why?
| | Humans | 96 | 2026 | 143875 | 0.660 |
Why?
| | Hemolytic-Uremic Syndrome | 1 | 2020 | 14 | 0.660 |
Why?
| | Hematologic Diseases | 2 | 2018 | 67 | 0.660 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 7 | 2021 | 69 | 0.630 |
Why?
| | Polymers | 6 | 2024 | 496 | 0.630 |
Why?
| | Recombinant Proteins | 4 | 2021 | 1372 | 0.620 |
Why?
| | Lipids | 3 | 2023 | 705 | 0.610 |
Why?
| | Hemophilia A | 1 | 2021 | 146 | 0.610 |
Why?
| | Blood Coagulation Disorders | 1 | 2020 | 191 | 0.570 |
Why?
| | Vascular Diseases | 3 | 2024 | 246 | 0.570 |
Why?
| | Receptors, Cell Surface | 7 | 2021 | 379 | 0.550 |
Why?
| | Transfusion Reaction | 3 | 2020 | 62 | 0.540 |
Why?
| | Disease Models, Animal | 16 | 2026 | 4544 | 0.530 |
Why?
| | beta-Thalassemia | 3 | 2025 | 36 | 0.520 |
Why?
| | Lipoproteins | 1 | 2018 | 164 | 0.520 |
Why?
| | Antigens, CD | 7 | 2021 | 550 | 0.520 |
Why?
| | Biomarkers | 6 | 2020 | 4244 | 0.510 |
Why?
| | Inflammation | 5 | 2026 | 2882 | 0.500 |
Why?
| | Lung | 7 | 2025 | 4119 | 0.490 |
Why?
| | Lipid Peroxidation | 8 | 2018 | 162 | 0.480 |
Why?
| | Acute Kidney Injury | 4 | 2018 | 834 | 0.460 |
Why?
| | Hemochromatosis | 1 | 2015 | 10 | 0.450 |
Why?
| | beta-Globins | 1 | 2015 | 8 | 0.450 |
Why?
| | Spleen | 4 | 2025 | 517 | 0.440 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2025 | 32 | 0.430 |
Why?
| | Glutaral | 3 | 2012 | 15 | 0.410 |
Why?
| | Exercise Tolerance | 3 | 2025 | 285 | 0.410 |
Why?
| | Rats, Sprague-Dawley | 10 | 2024 | 2531 | 0.410 |
Why?
| | Mice | 19 | 2026 | 18423 | 0.400 |
Why?
| | Gene Deletion | 1 | 2015 | 394 | 0.390 |
Why?
| | Rats | 15 | 2024 | 5610 | 0.390 |
Why?
| | Peroxidases | 3 | 2015 | 29 | 0.390 |
Why?
| | Male | 44 | 2026 | 71700 | 0.380 |
Why?
| | Magnetic Resonance Imaging | 1 | 2025 | 3806 | 0.380 |
Why?
| | Polyethylene Glycols | 5 | 2024 | 642 | 0.380 |
Why?
| | Models, Animal | 4 | 2020 | 392 | 0.370 |
Why?
| | Receptors, Scavenger | 6 | 2021 | 22 | 0.370 |
Why?
| | Blood Coagulation | 4 | 2022 | 271 | 0.360 |
Why?
| | Macrophages | 6 | 2023 | 1512 | 0.360 |
Why?
| | Cattle | 9 | 2022 | 989 | 0.350 |
Why?
| | Sodium Nitrite | 1 | 2011 | 39 | 0.340 |
Why?
| | Protein Binding | 9 | 2026 | 2270 | 0.330 |
Why?
| | Central Nervous System Diseases | 1 | 2011 | 73 | 0.320 |
Why?
| | Drug Carriers | 2 | 2008 | 130 | 0.320 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2011 | 296 | 0.320 |
Why?
| | Biopolymers | 1 | 2010 | 33 | 0.310 |
Why?
| | Heme Oxygenase-1 | 8 | 2025 | 72 | 0.310 |
Why?
| | Heme Oxygenase (Decyclizing) | 6 | 2013 | 22 | 0.310 |
Why?
| | Biological Transport | 2 | 2021 | 412 | 0.310 |
Why?
| | Biological Products | 3 | 2022 | 246 | 0.300 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 9 | 2015 | 144 | 0.300 |
Why?
| | Molecular Weight | 6 | 2024 | 326 | 0.300 |
Why?
| | Lung Diseases | 2 | 2015 | 789 | 0.300 |
Why?
| | Erythrocyte Deformability | 2 | 2023 | 19 | 0.290 |
Why?
| | Central Nervous System | 1 | 2011 | 269 | 0.290 |
Why?
| | Hemodynamics | 4 | 2023 | 1117 | 0.290 |
Why?
| | Analgesics, Opioid | 3 | 2024 | 1131 | 0.280 |
Why?
| | Amino Acids | 4 | 2021 | 511 | 0.280 |
Why?
| | Liver | 4 | 2025 | 1869 | 0.280 |
Why?
| | Microvessels | 2 | 2020 | 93 | 0.280 |
Why?
| | Endothelial Cells | 4 | 2024 | 847 | 0.270 |
Why?
| | Erythrocyte Indices | 2 | 2019 | 30 | 0.270 |
Why?
| | Proteome | 3 | 2025 | 495 | 0.270 |
Why?
| | Glucosephosphate Dehydrogenase | 2 | 2025 | 65 | 0.260 |
Why?
| | Plasma Exchange | 1 | 2007 | 18 | 0.260 |
Why?
| | Erythropoiesis | 2 | 2019 | 56 | 0.260 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2019 | 2057 | 0.260 |
Why?
| | Proteomics | 7 | 2025 | 1163 | 0.260 |
Why?
| | Uric Acid | 1 | 2008 | 163 | 0.250 |
Why?
| | Signal Transduction | 4 | 2019 | 5220 | 0.250 |
Why?
| | Myocardium | 4 | 2019 | 929 | 0.240 |
Why?
| | Extracorporeal Circulation | 1 | 2026 | 15 | 0.240 |
Why?
| | Blood Circulation | 1 | 2005 | 44 | 0.240 |
Why?
| | Methemoglobin | 4 | 2021 | 21 | 0.230 |
Why?
| | Vascular Remodeling | 2 | 2019 | 203 | 0.230 |
Why?
| | Circular Dichroism | 2 | 2021 | 148 | 0.230 |
Why?
| | Opioid-Related Disorders | 2 | 2024 | 577 | 0.220 |
Why?
| | Chromatography, Gel | 5 | 2010 | 129 | 0.220 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.220 |
Why?
| | Antioxidants | 1 | 2008 | 594 | 0.210 |
Why?
| | Mice, Inbred C57BL | 9 | 2025 | 6055 | 0.210 |
Why?
| | Riboflavin | 1 | 2024 | 15 | 0.210 |
Why?
| | Vasoconstriction | 4 | 2020 | 216 | 0.210 |
Why?
| | Vascular Resistance | 2 | 2016 | 365 | 0.210 |
Why?
| | Nitrogen Oxides | 1 | 2004 | 54 | 0.210 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2023 | 24 | 0.200 |
Why?
| | Aspirin | 2 | 2006 | 398 | 0.200 |
Why?
| | Nails | 1 | 2023 | 13 | 0.200 |
Why?
| | Equipment Design | 1 | 2025 | 533 | 0.200 |
Why?
| | Hemoglobin A | 4 | 2006 | 20 | 0.200 |
Why?
| | Muscle, Skeletal | 3 | 2025 | 1789 | 0.200 |
Why?
| | Intercellular Adhesion Molecule-1 | 2 | 2015 | 143 | 0.200 |
Why?
| | Blood Pressure | 6 | 2018 | 1758 | 0.200 |
Why?
| | Endothelium, Vascular | 3 | 2018 | 964 | 0.200 |
Why?
| | Equidae | 1 | 2022 | 7 | 0.190 |
Why?
| | Perfusion | 1 | 2024 | 243 | 0.190 |
Why?
| | Protein Engineering | 2 | 2018 | 111 | 0.190 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 247 | 0.190 |
Why?
| | Species Specificity | 2 | 2020 | 577 | 0.190 |
Why?
| | Radiation Injuries | 1 | 2023 | 150 | 0.180 |
Why?
| | Superoxides | 1 | 2022 | 208 | 0.180 |
Why?
| | Receptor, PAR-1 | 1 | 2022 | 16 | 0.180 |
Why?
| | Receptors, Thrombin | 1 | 2022 | 15 | 0.180 |
Why?
| | Intestinal Absorption | 1 | 2002 | 94 | 0.180 |
Why?
| | Mycoplasma hyorhinis | 1 | 2021 | 1 | 0.180 |
Why?
| | Methemoglobinemia | 2 | 2015 | 13 | 0.180 |
Why?
| | Magnetics | 1 | 2021 | 48 | 0.180 |
Why?
| | Fibrinolysis | 2 | 2022 | 163 | 0.180 |
Why?
| | Blood Coagulation Tests | 1 | 2021 | 72 | 0.180 |
Why?
| | Cell Line | 6 | 2015 | 2899 | 0.170 |
Why?
| | Ultraviolet Rays | 1 | 2024 | 401 | 0.170 |
Why?
| | Methemalbumin | 1 | 2021 | 1 | 0.170 |
Why?
| | Photoelectron Spectroscopy | 1 | 2021 | 6 | 0.170 |
Why?
| | Factor VIII | 1 | 2021 | 103 | 0.170 |
Why?
| | Tranexamic Acid | 1 | 2021 | 50 | 0.170 |
Why?
| | Free Radicals | 4 | 2015 | 110 | 0.170 |
Why?
| | Antifibrinolytic Agents | 1 | 2021 | 60 | 0.170 |
Why?
| | Pulmonary Artery | 3 | 2019 | 1123 | 0.170 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 66 | 0.170 |
Why?
| | Models, Biological | 4 | 2018 | 1831 | 0.170 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 31 | 0.170 |
Why?
| | Polymerization | 3 | 2023 | 128 | 0.160 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2020 | 32 | 0.160 |
Why?
| | Beta vulgaris | 1 | 2020 | 13 | 0.160 |
Why?
| | Hypertension | 3 | 2020 | 1261 | 0.160 |
Why?
| | Lung Transplantation | 1 | 2024 | 325 | 0.160 |
Why?
| | CD40 Antigens | 1 | 2021 | 91 | 0.160 |
Why?
| | Pharmaceutical Preparations | 1 | 2002 | 173 | 0.160 |
Why?
| | Membrane Lipids | 1 | 2020 | 82 | 0.160 |
Why?
| | Subarachnoid Space | 1 | 2019 | 9 | 0.160 |
Why?
| | Vasospasm, Intracranial | 1 | 2019 | 19 | 0.160 |
Why?
| | Cell-Derived Microparticles | 1 | 2020 | 73 | 0.150 |
Why?
| | Protein Unfolding | 1 | 2019 | 31 | 0.150 |
Why?
| | Spin Labels | 2 | 2025 | 54 | 0.150 |
Why?
| | Biotechnology | 1 | 2019 | 45 | 0.150 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2019 | 70 | 0.150 |
Why?
| | Rats, Inbred Lew | 1 | 2019 | 106 | 0.150 |
Why?
| | Blood Specimen Collection | 1 | 2019 | 38 | 0.150 |
Why?
| | Blotting, Western | 5 | 2015 | 1223 | 0.150 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2019 | 70 | 0.150 |
Why?
| | Ferritins | 2 | 2010 | 67 | 0.150 |
Why?
| | Equipment and Supplies | 1 | 2019 | 34 | 0.150 |
Why?
| | Nitrates | 2 | 2020 | 97 | 0.150 |
Why?
| | Osmotic Fragility | 2 | 2024 | 10 | 0.150 |
Why?
| | Toxicokinetics | 1 | 2018 | 9 | 0.150 |
Why?
| | Venous Thromboembolism | 1 | 2023 | 337 | 0.150 |
Why?
| | Female | 18 | 2026 | 77454 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2020 | 354 | 0.150 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 42 | 0.140 |
Why?
| | Antibodies | 1 | 2021 | 402 | 0.140 |
Why?
| | Cell Communication | 1 | 2020 | 318 | 0.140 |
Why?
| | Erythropoietin | 2 | 2018 | 99 | 0.140 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2621 | 0.140 |
Why?
| | Healthy Volunteers | 1 | 2019 | 214 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 1 | 2021 | 678 | 0.140 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 186 | 0.140 |
Why?
| | Lipocalin-2 | 1 | 2018 | 80 | 0.140 |
Why?
| | Plasma | 1 | 2020 | 223 | 0.140 |
Why?
| | Kidney Function Tests | 1 | 2018 | 161 | 0.140 |
Why?
| | Fibrin | 1 | 2019 | 91 | 0.140 |
Why?
| | Anemia | 1 | 2019 | 178 | 0.140 |
Why?
| | Metabolic Clearance Rate | 2 | 2012 | 117 | 0.140 |
Why?
| | Models, Cardiovascular | 1 | 2019 | 198 | 0.130 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 333 | 0.130 |
Why?
| | Liver Diseases | 1 | 2021 | 304 | 0.130 |
Why?
| | Neutrophil Activation | 1 | 2018 | 85 | 0.130 |
Why?
| | Hepcidins | 2 | 2015 | 22 | 0.130 |
Why?
| | Temperature | 1 | 2021 | 677 | 0.130 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2018 | 994 | 0.130 |
Why?
| | Physical Exertion | 1 | 2018 | 209 | 0.130 |
Why?
| | Serine Endopeptidases | 1 | 2018 | 130 | 0.130 |
Why?
| | Solutions | 2 | 2010 | 167 | 0.130 |
Why?
| | Oxymorphone | 1 | 2016 | 4 | 0.130 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 33 | 0.130 |
Why?
| | United States Food and Drug Administration | 1 | 2017 | 202 | 0.130 |
Why?
| | Metabolomics | 4 | 2025 | 715 | 0.130 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 333 | 0.130 |
Why?
| | Dogs | 3 | 2022 | 428 | 0.130 |
Why?
| | Treatment Outcome | 3 | 2019 | 11390 | 0.130 |
Why?
| | Proteins | 1 | 2023 | 1023 | 0.120 |
Why?
| | Disease Management | 1 | 2020 | 649 | 0.120 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1794 | 0.120 |
Why?
| | Swine | 4 | 2021 | 839 | 0.120 |
Why?
| | Microcirculation | 2 | 2020 | 138 | 0.120 |
Why?
| | Sepsis | 2 | 2020 | 640 | 0.120 |
Why?
| | Human Umbilical Vein Endothelial Cells | 4 | 2018 | 108 | 0.120 |
Why?
| | Cardiac Surgical Procedures | 1 | 2021 | 593 | 0.120 |
Why?
| | Spin Trapping | 1 | 2015 | 3 | 0.120 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 929 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 378 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 373 | 0.110 |
Why?
| | Disease Progression | 3 | 2023 | 2862 | 0.110 |
Why?
| | Heart | 1 | 2019 | 632 | 0.110 |
Why?
| | Protein Stability | 3 | 2012 | 175 | 0.110 |
Why?
| | Splenomegaly | 1 | 2015 | 15 | 0.110 |
Why?
| | Muscle Contraction | 1 | 2018 | 430 | 0.110 |
Why?
| | Procollagen-Proline Dioxygenase | 2 | 2011 | 27 | 0.110 |
Why?
| | Tissue Distribution | 2 | 2025 | 330 | 0.110 |
Why?
| | Cardiac Output | 2 | 2012 | 178 | 0.110 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2015 | 147 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 2 | 2015 | 566 | 0.110 |
Why?
| | Cell-Free System | 3 | 2011 | 53 | 0.100 |
Why?
| | Altitude | 1 | 2018 | 482 | 0.100 |
Why?
| | Hemorrhage | 1 | 2019 | 805 | 0.100 |
Why?
| | Prostatic Neoplasms | 1 | 2021 | 1058 | 0.100 |
Why?
| | Mesocricetus | 2 | 2026 | 46 | 0.100 |
Why?
| | Excipients | 2 | 2024 | 54 | 0.100 |
Why?
| | Adult | 6 | 2026 | 40114 | 0.100 |
Why?
| | Endotoxemia | 1 | 2014 | 87 | 0.100 |
Why?
| | Cross-Linking Reagents | 2 | 2012 | 208 | 0.100 |
Why?
| | Muscle Proteins | 1 | 2015 | 243 | 0.100 |
Why?
| | Cricetinae | 2 | 2026 | 301 | 0.100 |
Why?
| | Hemoglobin, Sickle | 2 | 2023 | 19 | 0.100 |
Why?
| | Creatinine | 2 | 2012 | 499 | 0.100 |
Why?
| | Reactive Oxygen Species | 2 | 2007 | 643 | 0.090 |
Why?
| | Models, Molecular | 3 | 2020 | 1624 | 0.090 |
Why?
| | Prognosis | 1 | 2021 | 4163 | 0.090 |
Why?
| | Malaria | 1 | 2013 | 68 | 0.090 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 34 | 0.090 |
Why?
| | Infusion Pumps | 1 | 2012 | 34 | 0.090 |
Why?
| | Exercise | 1 | 2024 | 2166 | 0.090 |
Why?
| | Macaca mulatta | 2 | 2025 | 191 | 0.090 |
Why?
| | Membrane Proteins | 3 | 2020 | 1177 | 0.090 |
Why?
| | Cardio-Renal Syndrome | 1 | 2012 | 14 | 0.090 |
Why?
| | Neutrophils | 1 | 2018 | 1134 | 0.090 |
Why?
| | Transcriptome | 2 | 2018 | 1034 | 0.090 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2023 | 97 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1669 | 0.090 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 373 | 0.090 |
Why?
| | Dimerization | 2 | 2010 | 197 | 0.090 |
Why?
| | Glycolysis | 2 | 2025 | 335 | 0.090 |
Why?
| | Tyrosine | 1 | 2012 | 229 | 0.090 |
Why?
| | Catechin | 1 | 2011 | 25 | 0.090 |
Why?
| | Occludin | 1 | 2011 | 12 | 0.090 |
Why?
| | Cohort Studies | 2 | 2021 | 5898 | 0.090 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2011 | 17 | 0.090 |
Why?
| | Cytokines | 2 | 2021 | 2099 | 0.090 |
Why?
| | Iron Chelating Agents | 1 | 2011 | 19 | 0.090 |
Why?
| | Surface Plasmon Resonance | 2 | 2008 | 89 | 0.090 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2011 | 81 | 0.090 |
Why?
| | Area Under Curve | 1 | 2012 | 328 | 0.090 |
Why?
| | Claudins | 1 | 2011 | 24 | 0.090 |
Why?
| | Basilar Artery | 2 | 2021 | 6 | 0.080 |
Why?
| | Heart Diseases | 1 | 2014 | 339 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2018 | 3634 | 0.080 |
Why?
| | Erythrocyte Aggregation | 1 | 2010 | 4 | 0.080 |
Why?
| | Filtration | 1 | 2010 | 69 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1505 | 0.080 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 154 | 0.080 |
Why?
| | Biophysics | 1 | 2010 | 76 | 0.080 |
Why?
| | Pyridones | 1 | 2011 | 198 | 0.080 |
Why?
| | Oxygen Consumption | 2 | 2024 | 718 | 0.070 |
Why?
| | Fatty Acids | 2 | 2023 | 453 | 0.070 |
Why?
| | Aorta | 1 | 2012 | 433 | 0.070 |
Why?
| | Atherosclerosis | 1 | 2013 | 407 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2011 | 337 | 0.070 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2008 | 9 | 0.070 |
Why?
| | Globins | 1 | 2008 | 21 | 0.070 |
Why?
| | alpha-Globins | 1 | 2008 | 9 | 0.070 |
Why?
| | Pneumonia | 1 | 2015 | 647 | 0.070 |
Why?
| | Cellular Senescence | 1 | 2011 | 227 | 0.070 |
Why?
| | Cells, Cultured | 3 | 2015 | 4183 | 0.070 |
Why?
| | Buffers | 1 | 2008 | 56 | 0.070 |
Why?
| | Hemin | 2 | 2021 | 4 | 0.070 |
Why?
| | Lasers | 2 | 2005 | 131 | 0.070 |
Why?
| | Ferric Compounds | 1 | 2008 | 55 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2017 | 450 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2025 | 2194 | 0.070 |
Why?
| | Protein Multimerization | 1 | 2009 | 205 | 0.070 |
Why?
| | Drug Stability | 1 | 2007 | 165 | 0.060 |
Why?
| | Tissue Engineering | 1 | 2011 | 435 | 0.060 |
Why?
| | Adenosine Triphosphate | 2 | 2010 | 488 | 0.060 |
Why?
| | Binding Sites | 2 | 2011 | 1329 | 0.060 |
Why?
| | Methionine | 1 | 2006 | 159 | 0.060 |
Why?
| | Pentetic Acid | 1 | 2005 | 12 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2018 | 346 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 577 | 0.060 |
Why?
| | Molecular Structure | 1 | 2007 | 504 | 0.060 |
Why?
| | Protein Structure, Quaternary | 2 | 2018 | 120 | 0.060 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 453 | 0.060 |
Why?
| | Raffinose | 1 | 2005 | 29 | 0.060 |
Why?
| | Cystine | 1 | 2005 | 18 | 0.060 |
Why?
| | Cysteine | 1 | 2006 | 212 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2321 | 0.060 |
Why?
| | Scattering, Radiation | 1 | 2005 | 101 | 0.060 |
Why?
| | Coronary Vessels | 2 | 2018 | 251 | 0.060 |
Why?
| | Child | 2 | 2023 | 22784 | 0.060 |
Why?
| | Time Factors | 2 | 2015 | 7042 | 0.050 |
Why?
| | Antimalarials | 1 | 2024 | 34 | 0.050 |
Why?
| | Peptides | 1 | 2010 | 981 | 0.050 |
Why?
| | Kinetics | 1 | 2008 | 1628 | 0.050 |
Why?
| | Chlorides | 1 | 2005 | 137 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2021 | 747 | 0.050 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2024 | 9 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2017 | 2543 | 0.050 |
Why?
| | Aerosols | 1 | 2025 | 180 | 0.050 |
Why?
| | Fish Oils | 1 | 2023 | 26 | 0.050 |
Why?
| | Particle Size | 1 | 2005 | 406 | 0.050 |
Why?
| | Acute Disease | 2 | 2021 | 1015 | 0.050 |
Why?
| | Models, Chemical | 1 | 2004 | 273 | 0.050 |
Why?
| | Heart Rate | 1 | 2007 | 849 | 0.050 |
Why?
| | Allografts | 1 | 2024 | 151 | 0.050 |
Why?
| | Ventricular Function, Right | 1 | 2025 | 293 | 0.050 |
Why?
| | Cercopithecidae | 1 | 2002 | 8 | 0.050 |
Why?
| | Piperidines | 1 | 2004 | 224 | 0.050 |
Why?
| | Drug Compounding | 1 | 2022 | 104 | 0.050 |
Why?
| | Regional Blood Flow | 1 | 2004 | 504 | 0.050 |
Why?
| | Risk Assessment | 1 | 2012 | 3585 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2024 | 1063 | 0.050 |
Why?
| | Administration, Intravenous | 1 | 2022 | 173 | 0.050 |
Why?
| | Protein Conformation | 1 | 2005 | 941 | 0.050 |
Why?
| | Hand | 1 | 2023 | 166 | 0.050 |
Why?
| | Biological Availability | 1 | 2002 | 137 | 0.050 |
Why?
| | Serum Albumin, Human | 1 | 2021 | 7 | 0.040 |
Why?
| | Young Adult | 1 | 2018 | 13998 | 0.040 |
Why?
| | Platelet Aggregation | 1 | 2022 | 102 | 0.040 |
Why?
| | Horses | 1 | 2022 | 202 | 0.040 |
Why?
| | Platelet Activation | 1 | 2022 | 100 | 0.040 |
Why?
| | Cell Survival | 2 | 2018 | 1136 | 0.040 |
Why?
| | Etanercept | 1 | 2021 | 61 | 0.040 |
Why?
| | Nitrites | 2 | 2013 | 88 | 0.040 |
Why?
| | Carnitine | 1 | 2021 | 87 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 55 | 0.040 |
Why?
| | Cell Movement | 1 | 2005 | 973 | 0.040 |
Why?
| | Triage | 1 | 2023 | 252 | 0.040 |
Why?
| | ADAMTS13 Protein | 1 | 2020 | 7 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 240 | 0.040 |
Why?
| | Kynurenine | 1 | 2021 | 115 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 291 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 589 | 0.040 |
Why?
| | Monocytes | 1 | 2023 | 545 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1986 | 0.040 |
Why?
| | von Willebrand Factor | 1 | 2020 | 84 | 0.040 |
Why?
| | Tryptophan | 1 | 2021 | 181 | 0.040 |
Why?
| | Middle Aged | 2 | 2021 | 35428 | 0.040 |
Why?
| | Blood Donors | 1 | 2021 | 118 | 0.040 |
Why?
| | Administration, Oral | 1 | 2002 | 842 | 0.040 |
Why?
| | Cardiopulmonary Bypass | 1 | 2021 | 217 | 0.040 |
Why?
| | Blood Banks | 1 | 2019 | 47 | 0.040 |
Why?
| | Lactic Acid | 1 | 2021 | 308 | 0.040 |
Why?
| | Cerebrospinal Fluid | 1 | 2019 | 91 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2019 | 61 | 0.040 |
Why?
| | Gadolinium | 1 | 2019 | 86 | 0.040 |
Why?
| | Organ Culture Techniques | 1 | 2019 | 158 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 190 | 0.040 |
Why?
| | Transfection | 1 | 2021 | 950 | 0.040 |
Why?
| | Intracranial Aneurysm | 1 | 2019 | 100 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 590 | 0.040 |
Why?
| | Endothelins | 1 | 2018 | 63 | 0.030 |
Why?
| | Tissue Donors | 1 | 2021 | 412 | 0.030 |
Why?
| | Blood Platelets | 1 | 2022 | 396 | 0.030 |
Why?
| | Blood Safety | 1 | 2017 | 11 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2021 | 510 | 0.030 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2021 | 246 | 0.030 |
Why?
| | Hemodilution | 2 | 2008 | 11 | 0.030 |
Why?
| | Vasodilation | 1 | 2021 | 517 | 0.030 |
Why?
| | Finite Element Analysis | 1 | 2018 | 75 | 0.030 |
Why?
| | Viscosity | 1 | 2018 | 93 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 280 | 0.030 |
Why?
| | Precision Medicine | 1 | 2022 | 446 | 0.030 |
Why?
| | Anemia, Hemolytic | 1 | 2017 | 16 | 0.030 |
Why?
| | Metabolome | 1 | 2020 | 374 | 0.030 |
Why?
| | Protein Structure, Tertiary | 2 | 2011 | 863 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2015 | 2167 | 0.030 |
Why?
| | Sheep | 1 | 2019 | 886 | 0.030 |
Why?
| | Acclimatization | 1 | 2018 | 172 | 0.030 |
Why?
| | Exchange Transfusion, Whole Blood | 2 | 2006 | 16 | 0.030 |
Why?
| | Transcription Factors | 1 | 2004 | 1754 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1839 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1062 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2020 | 587 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2016 | 178 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 574 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2020 | 2021 | 0.030 |
Why?
| | Electric Impedance | 1 | 2015 | 112 | 0.030 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2015 | 74 | 0.030 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2015 | 98 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2019 | 755 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2015 | 2854 | 0.030 |
Why?
| | Drug Synergism | 1 | 2015 | 370 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2018 | 588 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 423 | 0.030 |
Why?
| | Apoptosis | 2 | 2014 | 2519 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 394 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2939 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2013 | 112 | 0.020 |
Why?
| | Body Mass Index | 1 | 2021 | 2432 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2017 | 781 | 0.020 |
Why?
| | Mitochondria | 1 | 2019 | 988 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2013 | 165 | 0.020 |
Why?
| | Phagocytosis | 1 | 2014 | 291 | 0.020 |
Why?
| | Iron Metabolism Disorders | 1 | 2011 | 6 | 0.020 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2011 | 21 | 0.020 |
Why?
| | Deferoxamine | 1 | 2011 | 26 | 0.020 |
Why?
| | Siderophores | 1 | 2011 | 12 | 0.020 |
Why?
| | Hydroxylation | 1 | 2011 | 47 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2017 | 1675 | 0.020 |
Why?
| | Injections, Intraperitoneal | 1 | 2011 | 116 | 0.020 |
Why?
| | Cobalt | 1 | 2011 | 51 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2011 | 89 | 0.020 |
Why?
| | DNA Damage | 1 | 2014 | 446 | 0.020 |
Why?
| | Ligands | 1 | 2013 | 670 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 554 | 0.020 |
Why?
| | Bioreactors | 1 | 2011 | 49 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 368 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2011 | 112 | 0.020 |
Why?
| | Tight Junctions | 1 | 2011 | 78 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2944 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 861 | 0.020 |
Why?
| | Hemoglobinuria | 1 | 2010 | 3 | 0.020 |
Why?
| | Glucose Oxidase | 1 | 2010 | 25 | 0.020 |
Why?
| | Caspase 3 | 1 | 2011 | 252 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3112 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2010 | 202 | 0.020 |
Why?
| | Nitroso Compounds | 1 | 2009 | 7 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3210 | 0.020 |
Why?
| | Nitric Oxide Donors | 1 | 2009 | 21 | 0.020 |
Why?
| | Blood Component Transfusion | 1 | 2010 | 100 | 0.020 |
Why?
| | Astrocytes | 1 | 2011 | 219 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7918 | 0.020 |
Why?
| | Canada | 1 | 2010 | 434 | 0.020 |
Why?
| | Glutathione | 1 | 2010 | 373 | 0.020 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2010 | 261 | 0.020 |
Why?
| | Nitric Oxide Synthase | 1 | 2008 | 241 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 763 | 0.020 |
Why?
| | Heart Failure | 1 | 2021 | 2138 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2008 | 241 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2899 | 0.020 |
Why?
| | Peroxides | 1 | 2006 | 18 | 0.020 |
Why?
| | Erythrocyte Membrane | 1 | 2006 | 52 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 898 | 0.020 |
Why?
| | Nephelometry and Turbidimetry | 1 | 2005 | 15 | 0.010 |
Why?
| | Osmotic Pressure | 1 | 2005 | 34 | 0.010 |
Why?
| | Rabbits | 1 | 2006 | 665 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2009 | 542 | 0.010 |
Why?
| | Endocytosis | 1 | 2005 | 169 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2005 | 382 | 0.010 |
Why?
| | Endosomes | 1 | 2005 | 143 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1511 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2005 | 702 | 0.010 |
Why?
| | United States | 1 | 2017 | 15592 | 0.010 |
Why?
|
|
Buehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|